GE HealthCare Reports Steady 1Q23 Results; Maintain ‘Buy’ Rating

GEHC, $81.52, Market Capitalization $37.1 billion), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, reported 1Q23 results with a beat on both revenue and EPS versus consensus.